Table 6.
Sites of recurrence
| Surgery group (103 patients) | SEMS group (113 patients) | TADT group (85 patients) | |
|---|---|---|---|
| Number of patients (%) | Number of patients (%) | Number of patients (%) | |
| Liver | 8 (7.8) | 16 (14.2) | 9 (10.6) |
| Lung | 2 (1.9) | 5 (4.4) | 11 (12.9) |
| Peritoneum | 4 (3.9) | 6 (5.3) | 8 (9.4) |
| Lymph node | 3 (2.9) | 6 (5.3) | 2 (2.4) |
| Local | 4 (3.9) | 5 (4.4) | 4 (4.7) |
| Brain | 1 (1.0) | ||
| Liver+lung | 3 | ||
| Liver+peritoneum | 1 | 1 | |
| Lung+lymph node | 1 | ||
| Peritoneum+lymph node+local | 1 | ||
| Total | 21 (20.4) | 35 (31.0) | 33 (38.8)* |
*Total recurrence rate was higher in the TADT group than in the Surgery group (p = 0.006, OR 0.470, 95% Conf. int. 0.211, 0.772)